Skip to main content

JANUS HENDERSON GROUP PLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1274173 LONDON, X0

Position in LGND

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$201,624,736
+$13,424,460 QoQ
Shares Held
1,009,891
+1.5% QoQ
Ownership
5.04%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 96.49259177475588.ToString("F0")% None 3.5074082252441103.ToString("F0")%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANUS HENDERSON GROUP PLC holds $15,891,244,813 across 182 Biotechnology names. LGND ranks #18 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LGND

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $201,624,736 1,009,891
2025-12-31 $188,200,276 995,400
2025-09-30 $184,646,837 1,042,378
2025-06-30 $120,584,239 1,060,734
2025-03-31 $108,036,500 1,027,549
2024-12-31 $108,759,713 1,015,023
2024-09-30 $101,000,218 1,009,094
2024-06-30 $84,995,841 1,008,733
2024-03-31 $73,719,666 1,008,477
2023-12-31 $95,928,057 1,343,154
2023-09-30 $80,405,028 1,341,873
2023-06-30 $96,942,413 1,344,555
2023-03-31 $92,677,138 1,259,885
2022-12-31 $83,852,234 1,255,273
2022-09-30 $67,810,002 1,262,333
2022-06-30 $77,336,260 1,389,488
2022-03-31 $97,477,358 1,389,067
2021-12-31 $138,858,339 1,441,085
2021-09-30 $127,143,564 1,462,900
2021-06-30 $118,195,479 1,444,221
2021-03-31 $119,620,142 1,257,797
2020-12-31 $100,031,211 1,612,369
2020-09-30 $95,500,819 1,606,041
2020-06-30 $111,987,702 1,604,974
2020-03-31 $72,201,958 1,591,582